[general Administration of Market Supervision imposes administrative penalties on two pharmaceutical companies in accordance with the law] the reporter learned from the General Administration of Market Supervision today that the General Administration of Market Supervision imposed administrative penalties on Broad Pharmaceutical (China) Co., Ltd. and Wuhan Huihai Pharmaceutical Co., Ltd. in accordance with the law for reaching and implementing a monopoly agreement and abusing their dominant market position, and ordered Broad Pharmaceutical and Wuhan Huihai to stop their illegal activities. 149 million yuan of illegal income from Broad University Pharmaceutical was confiscated and fined 136 million yuan. The illegal income of Wuhan Huihai was confiscated 30.9248 million yuan and fined 4.1268 million yuan.